Pfizer (PFE)

$26.55 0.19 (0.72%)

12:27 EST PFE Stock Quote Delayed 30 Minutes

7 High-Yield Dividend Stocks That Work While You Sleep

By Josh Enomoto, InvestorPlace Contributor Jun 4, 2024

Although seemingly most of the celebrated ideas on financial publications center on high-growth plays, investors should spare some thought toward high-yield dividend stocks. In particular,…

Retirement Roadblocks: 7 Stocks to Avoid as You Near the Finish Line

7 Overlooked Stocks That Belong in Every Portfolio

3 Discounted Stocks Poised for a Major Upswing

Volume:

Previous Close -

Market Cap 148.84B

PE Ratio 35.40

EPS 0.75

Volume (Avg. Vol.) 12.48M

Day's Range $26.46 - $26.78

52-Week Range $24.48 - $31.54

Dividend & Yield $1.68 (6.33%)

PFE Stock Predictions, Articles, and Pfizer News

Blue-Chip Blunders: 7 Stocks to Sell as Management Missteps Mount

By Thomas Niel, InvestorPlace Contributor Jun 2, 2024

Sometimes top companies make bottom-shelf decisions; such is the case with these seven blue-chip stocks to sell.

Steady Gains, Solid Yields: 7 Low-Beta Stocks Paying 5%+ Dividends

By Faisal Humayun, InvestorPlace Contributor May 30, 2024

These are the low-beta dividend stocks to buy, as they represent companies with strong fundamentals and robust cash flow visibility.

7 Must-Own Stocks to Hold for the Second Half of 2024

By Yiannis Zourmpanos, InvestorPlace Contributor May 29, 2024

Explore 7 must-own stocks for the second half of the year set to drive substantial yields across multiple innovative sectors.

If You Can Only Buy One Value Stock in May, It Better Be One of These 3 Names

By Josh Enomoto, InvestorPlace Contributor May 29, 2024

Everyone loves discounts and that’s essentially what value stocks to buy represent. The difference, though, between a value play and a “cheap” security comes down…

Revenge of the Apes: 3 Reddit WallStreetBets Stocks That Could Pop Next

By Omor Ibne Ehsan May 28, 2024

The retail trading army could cause potential breakouts in these three WallStreetBets stocks that are being discussed more and more.

Dividend Deals: 3 Overlooked Stocks Offering Incredible Value

By Vandita Jadeja May 27, 2024

Build a portfolio that steadily generates passive income for you. Here are three overlooked dividend stocks to consider.

The Savvy Investor’s Cheat Sheet: 3 Deep Value Picks for May 2024

By Joey Frenette, InvestorPlace Contributor May 23, 2024

There are a few potentialy deep value stocks to buy that investors may wish to put on their watchlists by summer.

3 Biotech Stocks to Buy on the Dip: May 2024

By Joel Lim, InvestorPlace Contributor May 23, 2024

These biotech giants offer investors the best opportunity money can buy for excellent profits and returns this year.

7 Safe-Haven Stocks to Weather Any Storm

By Yiannis Zourmpanos, InvestorPlace Contributor May 22, 2024

Explore top safe-haven stocks to buy now for stability and consistent growth during economic turbulence and uncertainty.

3 Healthcare Stocks to Buy Now: May 2024

By Ian Bezek, InvestorPlace Contributor May 21, 2024

Healthcare stocks can perform well during times of heightened inflation and economic uncertainty. These are three to buy today.

3 Blue-Chip Stocks to Buy on the Dip: May 2024

By Michael Que, InvestorPlace Contributor May 21, 2024

The economy is going to preform well and you need to invest. These are the three blue-chip stocks to buy on the dip before they skyrocket.

3 Blue-Chip Stocks Set to Triple Soon

By Noah Bolton, InvestorPlace Contributor May 20, 2024

Blue-chip stocks are great additions to a portfolio. If you're looking for consistent returns, check out these blue-chip stocks to buy.

7 Value Stocks to Buy and Hold for a Decade of Dominance

By Yiannis Zourmpanos, InvestorPlace Contributor May 17, 2024

Discover the enduring value of seven key value stocks to buy and hold in diverse sectors, presenting unparalleled opportunities.

7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs

By Alex Sirois, InvestorPlace Contributor May 16, 2024

AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.

7 Cheap Value Stocks to Buy Now: May 2024

By Ian Bezek, InvestorPlace Contributor May 15, 2024

Worried about a potential market correction? These seven cheap value stocks are bargains today regardless of the broader economic climate.

Biotech Behemoths: 3 Giants Set to Dominate the Health Scene

By Joey Frenette, InvestorPlace Contributor May 14, 2024

The biotech behemoths stand out as compelling and exciting options for investors seeking steady long-term growth.

7 F-Rated Stock Picks to Avoid Like the Plague in May

By Louis Navellier and the InvestorPlace Research Staff May 10, 2024

Consumer stocks, electric vehicle companies and meme stocks top the list of F-rated stock picks to avoid this month.

The 3 Most Undervalued Healthcare Stocks to Buy in May 2024

By Faisal Humayun, InvestorPlace Contributor May 10, 2024

These are the undervalued healthcare stocks to buy as they represent companies with steady growth visibility.

Safeguard Your Future: Top 3 Stocks to Weather Any Market Downturn

By Yiannis Zourmpanos, InvestorPlace Contributor May 9, 2024

Explore three stocks that will resist a market downturn that offer both stability and potential growth during economic fluctuations.

3 Profitable Dividend Stocks to Buy at Near-Lows

By Charles Munyi, InvestorPlace Contributor May 9, 2024

With high yields above 3% and dirt-cheap valuations, these undervalued dividend stocks present a significant margin of safety.

Pfizer (PFE)

7 High-Yield Dividend Stocks That Work While You Sleep

Retirement Roadblocks: 7 Stocks to Avoid as You Near the Finish Line

7 Overlooked Stocks That Belong in Every Portfolio

3 Discounted Stocks Poised for a Major Upswing

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Pfizer (PFE)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

PFE Stock Predictions, Articles, and Pfizer News

Subscriber Sign in